Mycoplasma in Poultry: Clinical Signs, Eye Infections, Treatment, and Control

Introduction

Avian mycoplasmosis is a globally significant disease complex affecting commercial poultry flocks, backyard chickens, turkeys, game birds, and occasionally waterfowl. The disease is primarily caused by Mycoplasma gallisepticum (MG) and, to a lesser extent, Mycoplasma synoviae (MS) and Mycoplasma meleagridis in turkeys. These cell wall-deficient bacteria belong to the class Mollicutes and are characterized by their small genome size, fastidious growth requirements, and ability to cause chronic respiratory tract infections, synovitis, and ocular disease. The economic impact of mycoplasma infections in poultry arises from reduced egg production, decreased feed conversion efficiency, increased mortality, carcass condemnation, and the cost of control programs.

This article provides a detailed review of the clinical presentation, pathogenesis of ocular infections, diagnostic approaches, treatment regimens, and integrated control strategies for mycoplasma in poultry, with emphasis on MG as the archetypal pathogen.

Etiology and Species Overview

Mycoplasmas are the smallest self-replicating prokaryotes. They lack a cell wall, which confers intrinsic resistance to beta-lactam antibiotics and complicates Gram staining. The principal pathogenic species in poultry are listed in Table 1.

Table 1. Principal Mycoplasma Species Infecting Poultry

M. gallisepticum remains the most economically important species and is the focus of the following sections.

Transmission and Pathogenesis

Horizontal transmission occurs via aerosolized respiratory droplets, direct contact with infected birds, contaminated feed, water, and fomites (including clothing, equipment, and transport crates). Vertical transmission through the egg is a critical feature of MG and MS epidemiology. Infected breeder hens can shed mycoplasmas into the egg yolk and albumen, leading to infected progeny that may appear clinically normal at hatch but develop disease under stress.

The pathogenesis of mycoplasma infection involves adherence to ciliated respiratory epithelial cells via specialized attachment organelles (e.g., the GapA adhesin in MG). This binding disrupts mucociliary clearance, promoting secondary bacterial infections (e.g., Escherichia coli as seen in Escherichia coli in Chickens and Poultry Products). The organism induces a chronic inflammatory response characterized by lymphoplasmacytic infiltration, mucosal thickening, and exudate accumulation. The immune response is often ineffective at clearing the infection, leading to persistent colonization.

Clinical Signs

The clinical presentation of mycoplasma in poultry depends on the species, age, immune status, concurrent infections, and environmental stressors. The classic syndrome is Chronic Respiratory Disease (CRD) in chickens.

Chronic Respiratory Disease (CRD)

• Respiratory Signs: Coughing, sneezing, tracheal rales, nasal discharge, and dyspnea. The disease often has an insidious onset and prolonged course.
• Ocular Signs: Conjunctivitis, periorbital swelling, foamy ocular discharge, and in severe cases, blepharospasm and corneal opacity. Ocular involvement is particularly common in young birds and can be the first observable sign.
• Systemic Signs: Reduced feed intake, decreased growth rate, lowered egg production (often by 10-20%), and increased mortality if complicated by secondary infections.
• Sinustis: In turkeys, infraorbital sinus swelling is characteristic, often with caseous exudate.

Mycoplasma synoviae Infection

• Respiratory Form: Often subclinical; detectable through serology or PCR.
• Articular Form: Lameness, swelling of the hock and foot joints, breast blisters, and reluctance to move. This form can mimic Staphylococcus or Streptococcus arthritis.
• Eggshell Apex Abnormalities: MS is associated with thinning, roughening, and translocation of the eggshell apex.

Eye Infections: Clinical Presentation and Pathophysiology

Ocular mycoplasmosis is a hallmark of MG infection in chickens, especially in the absence of good biosecurity. The eye is a primary entry point for the organism, and the conjunctival mucosa provides a suitable environment for adherence and colonization.

Clinical Features of Mycoplasma Chicken Eye Infection:

• Bilateral Conjunctivitis: Initially serous, later mucopurulent discharge. The conjunctiva becomes hyperemic and edematous.
• Periocular Dermatitis: Feather loss and crusting around the eyes due to lacrimation and rubbing.
• Keratoconjunctivitis: Corneal neovascularization, edema, and ulceration can occur in severe cases, leading to blindness.
• Secondary Infections: Damaged corneal epithelium predisposes to bacterial keratitis, often with opportunistic pathogens such as Avibacterium paragallinarum (the agent of Infectious Coryza in Chickens and Quail) or E. coli.

The pathophysiological mechanism involves direct cytopathic effects of mycoplasma adhesins and secreted metabolites (e.g., hydrogen peroxide, superoxide radicals) that damage epithelial cells. The ensuing inflammatory response recruits heterophils and macrophages, leading to tissue necrosis and scar formation.

Diagnosis

Accurate diagnosis is essential for implementing effective control measures. A combination of clinical observation, serology, molecular testing, and culture is recommended.

Serological Methods

• Rapid Serum Agglutination (RSA) Test: A simple, inexpensive screening test using stained antigen. High sensitivity but moderate specificity; false positives can occur with cross-reacting antibodies (e.g., after vaccination with killed MG vaccines). Positive results should be confirmed by ELISA or PCR.
• ELISA: Commercial ELISA kits detect antibodies against MG or MS. They are suitable for flock-level surveillance and can differentiate between vaccinated and naturally infected birds when used with appropriate cutoffs. For technical principles, refer to Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus (though that article uses FeLV antigen, the method for antibody detection in avian sera follows similar principles).
• Hemagglutination Inhibition (HI) Test: More specific than RSA but less commonly used in routine monitoring. It is the gold standard for differentiating MG serotypes.

Molecular Detection

• Conventional PCR: Target genes include the 16S rRNA gene, the mgc2 gene (MG-specific), or the gapA gene. PCR has high sensitivity and specificity and can detect the organism in tracheal swabs, choanal cleft swabs, conjunctival swabs, or tissue samples.
• Real-Time PCR (qPCR): Allows quantification of bacterial load and is useful for monitoring treatment response. Multiplex assays can simultaneously detect MG, MS, and M. meleagridis.
• Loop-Mediated Isothermal Amplification (LAMP): A field-friendly alternative that does not require thermocyclers; useful for point-of-care testing in resource-limited settings.

Culture and Isolation

Culture is the definitive diagnostic method but is slow (7-21 days) and requires specialized media (e.g., Frey's medium or modified Hayflick's medium). Isolation is important for antimicrobial susceptibility testing, but routine diagnostic use has declined in favor of PCR.

Necropsy and Histopathology

Gross lesions in CRD include caseous airsacculitis, pneumonia, tracheitis, and serositis. In ocular cases, the conjunctiva is thickened and may have purulent exudate. Histologically, there is a lymphoplasmacytic infiltration, epithelial hyperplasia, and loss of cilia.

Treatment

Treatment of mycoplasma in poultry is challenging due to the organism's intrinsic resistance to many antibiotics, its intracellular location, and the lack of a cell wall. Antimicrobial therapy can reduce clinical signs and shedding but rarely achieves complete eradication.

Antibiotic Classes

• Macrolides: Tylosin, tilmicosin, tylosin phosphate, and gamithromycin are commonly used. They inhibit protein synthesis by binding to the 50S ribosomal subunit. Tylosin is often administered in feed or drinking water for 3-5 days.
• Tetracyclines: Chlortetracycline and oxytetracycline are effective but face increasing resistance in some regions. They are often used in combination with macrolides.
• Fluoroquinolones: Enrofloxacin and difloxacin have good penetration into respiratory tissues but are subject to regulatory restrictions in many countries due to concerns about antimicrobial resistance and food safety.
• Pleuromutilins: Tiamulin and valnemulin are highly active against mycoplasmas and are used in feed medication.
• Aminoglycosides: Gentamicin and spectinomycin have limited efficacy but may be used in combination therapy.

Table 2. Common Antibiotic Regimens for Mycoplasma in Poultry

Supportive Care

In flocks with severe respiratory or ocular disease, supportive measures include improving ventilation, reducing ammonia levels, providing clean litter, and ensuring adequate nutrition. For eye infections, gentle flushing of the conjunctival sac with sterile saline can remove exudate. Secondary bacterial infections should be treated according to culture and sensitivity results.

Treatment Failure

Failure of antibiotic therapy can result from:

• Inadequate dose or duration.
• Poor bioavailability (especially with feed medications in sick, anorexic birds).
• Antimicrobial resistance.
• Reinfection from environmental reservoirs or vertically infected progeny.
• Concurrent viral or bacterial infections (e.g., Highly Pathogenic Avian Influenza (H5N1) in Poultry and Wild Birds or Necrotic Enteritis in Broiler Chickens).

Control and Prevention

A multifaceted approach combining biosecurity, vaccination, and antimicrobial stewardship is necessary for effective control.

Biosecurity

• All-in/all-out production and thorough cleaning and disinfection between flocks.
• Rodent and wild bird control to prevent introduction of mycoplasmas from outside sources.
• Dedicated farm clothing and equipment per house.
• Quarantine of replacement stock and serological testing before introduction.

Eradication Programs

In many commercial breeding operations, MG and MS are targets for eradication. This involves:

• Testing all breeder flocks serologically and bacteriologically.
• Eliminating positive flocks by depopulation.
• Replacing with mycoplasma-free stock from certified sources.

Vaccination

Vaccines for MG are available and used primarily in multi-age layer operations where eradication is not feasible.

Types of MG Vaccines:

• Live attenuated vaccines: Strains such as ts-11 and 6/85 are administered via eye drop, coarse spray, or drinking water. They induce mucosal and systemic immunity but can cause mild vaccine reactions. They do not protect against all circulating field strains.
• Bacterins (killed vaccines): Inactivated oil-emulsion vaccines administered intramuscularly. They reduce egg production losses but provide limited protection against respiratory infection.
• Recombinant vaccines: Vector vaccines using fowlpox virus or E. coli expressing MG antigens are under development but not yet widely commercialized.

Vaccination does not prevent infection but reduces shedding and clinical disease. It should be combined with good biosecurity and regular monitoring.

Monitoring and Surveillance

Regular serological monitoring (every 6-8 weeks) of sentinel birds or random samples is recommended. PCR on tracheal swabs can detect early infection before seroconversion. Any positive flock should be investigated and managed according to the farm's health plan.

Decision Tree for Mycoplasma Management

The following Mermaid diagram outlines a decision tree for managing a suspected MG outbreak in a commercial layer flock.

graph TD
    A[Suspected MG outbreak<br>Respiratory signs + drop in egg production], > B{Conduct diagnostics}
    B, > C[Collect tracheal swabs<br>for PCR and culture]
    B, > D[Collect serum samples<br>for RSA and ELISA]
    C, > E{PCR positive?}
    E, Yes, > F[Confirm with culture if needed]
    E, No, > D
    F, > G{History of vaccination?}
    G, Yes, > H[Differential: vaccine reaction vs. field strain<br>Sequence mgc2 gene]
    G, No, > I[Confirmed field MG infection]
    I, > J[Implement control measures]
    J, > K{Production type}
    K, Breeder, > L[Depopulation if possible or treat all birds<br>Consider antibiotic therapy for affected]
    K, Layer, > M[Vaccinate remaining birds<br>Treat with tylosin/tiamulin in water]
    K, Broiler, > N[Treat entire flock with antibiotic<br>Increase biosecurity]
    L, > O[Monitor shedding and serology post-treatment]
    M, > O
    N, > O
    O, > P{Clear?}
    P, Yes, > Q[Resume normal protocols]
    P, No, > R[Re-evaluate antibiotic sensitivity<br>Consider culling high shedders]
    R, > O

Differential Diagnosis

Several other respiratory and ocular diseases of poultry can mimic mycoplasmosis. A thorough diagnostic workup is essential to avoid misdiagnosis. Important differentials include:

• Infectious Coryza: Caused by Avibacterium paragallinarum; presents with facial swelling, nasal discharge, and conjunctivitis. It can be differentiated by Gram stain (Gram-negative bacilli) and PCR (Infectious Coryza in Poultry and Ducks).
• Avian Cholera: Caused by Pasteurella multocida; acute septicemia with high mortality (Fowl Cholera in Poultry).
• Avian Influenza and Newcastle Disease: Both cause respiratory signs, conjunctivitis, and egg drop; require highly specific molecular testing.
• Aspergillosis: Fungal pneumonia and airsacculitis in young birds; ocular involvement is rare.
• Vitamin A Deficiency: Can cause conjunctivitis and ocular discharge; diagnosed by dietary history and response to supplementation.

Conclusion

Mycoplasma infections, particularly those caused by M. gallisepticum, remain a major challenge in poultry production worldwide. The subtle onset of Clinical Respiratory Disease and its exacerbation by management stressors necessitate vigilant surveillance. Ocular infections are an important clinical feature that can lead to significant welfare issues and production losses. Diagnosis relies on a combination of molecular, serological, and culture methods. Treatment with macrolides and tetracyclines can reduce clinical severity but does not eliminate the organism. Control is best achieved through a comprehensive program of biosecurity, vaccination where appropriate, and eventual eradication in breeding stock. Integration of these strategies with the broader principles of poultry health management is essential for sustainable production.

References

1. Ley DH. Mycoplasma gallisepticum infection. In: Swayne DE, editor. Diseases of Poultry. 14th ed. Wiley-Blackwell; 2020. p. 912-952.
2. World Organisation for Animal Health (WOAH). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.3.5: Avian Mycoplasmosis (Mycoplasma gallisepticum, M. synoviae). 2022 edition. Available at: https://www.woah.org.
3. Kleven SH. Control of avian mycoplasma infections in commercial poultry. Avian Diseases. 2008;52(3):367-371.
4. Raviv Z, Ley DH. Mycoplasma meleagridis infection. In: Swayne DE, editor. Diseases of Poultry. 14th ed. Wiley-Blackwell; 2020. p. 953-958.
5. Nascimento ER, Pereira VLA, Nascimento MGF. Diagnostic methods for Mycoplasma gallisepticum and M. synoviae in poultry: a review. Brazilian Journal of Poultry Science. 2016;18(4):569-580.